164 related articles for article (PubMed ID: 25860945)
1. APOE polymorphisms contribute to reduced atorvastatin response in Chilean Amerindian subjects.
Lagos J; Zambrano T; Rosales A; Salazar LA
Int J Mol Sci; 2015 Apr; 16(4):7890-9. PubMed ID: 25860945
[TBL] [Abstract][Full Text] [Related]
2. Influence of SREBP-2 and SCAP gene polymorphisms on lipid-lowering response to atorvastatin in a cohort of Chilean subjects with Amerindian background.
Lagos J; Zambrano T; Rosales A; Salazar LA
Mol Diagn Ther; 2014 Aug; 18(4):435-43. PubMed ID: 24615250
[TBL] [Abstract][Full Text] [Related]
3. SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals.
Prado Y; Saavedra N; Zambrano T; Lagos J; Rosales A; Salazar LA
Int J Mol Sci; 2015 Aug; 16(9):20609-19. PubMed ID: 26334272
[TBL] [Abstract][Full Text] [Related]
4. Influence of Amerindian mitochondrial DNA haplogroups on thrombosis susceptibility and frequency of four genetic prothrombotic variants in Southern Chilean subjects.
Guzmán N; Lanas F; Salazar LA
Clin Chim Acta; 2010 Mar; 411(5-6):444-7. PubMed ID: 20064497
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin.
Cerda A; Genvigir FD; Willrich MA; Arazi SS; Bernik MM; Dorea EL; Bertolami MC; Faludi AA; Hirata MH; Hirata RD
Lipids Health Dis; 2011 Nov; 10():206. PubMed ID: 22074026
[TBL] [Abstract][Full Text] [Related]
6. Selected LDLR and APOE Polymorphisms Affect Cognitive and Functional Response to Lipophilic Statins in Alzheimer's Disease.
de Oliveira FF; Chen ES; Smith MC; Bertolucci PHF
J Mol Neurosci; 2020 Oct; 70(10):1574-1588. PubMed ID: 32474901
[TBL] [Abstract][Full Text] [Related]
7. Characterization of LDLR rs5925 and PCSK9 rs505151 genetic variants frequencies in healthy subjects from northern Chile: Influence on plasma lipid levels.
Rojas C; Ramírez H; Salazar LA; Kalergis AM; Gálvez AS; Escobar-Vera J
J Clin Lab Anal; 2019 Nov; 33(9):e23001. PubMed ID: 31441123
[TBL] [Abstract][Full Text] [Related]
8. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin.
Cerda A; Genvigir FD; Arazi SS; Hirata MH; Dorea EL; Bernik MM; Bertolami MC; Faludi AA; Hirata RD
Clin Chim Acta; 2010 May; 411(9-10):631-7. PubMed ID: 20064494
[TBL] [Abstract][Full Text] [Related]
9. Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia.
Rosales A; Alvear M; Cuevas A; Saavedra N; Zambrano T; Salazar LA
Clin Chim Acta; 2012 Feb; 413(3-4):495-501. PubMed ID: 22120734
[TBL] [Abstract][Full Text] [Related]
10. HMGCR rs17671591 SNP Determines Lower Plasma LDL-C after Atorvastatin Therapy in Chilean Individuals.
Cuevas A; Fernández C; Ferrada L; Zambrano T; Rosales A; Saavedra N; Salazar LA
Basic Clin Pharmacol Toxicol; 2016 Apr; 118(4):292-7. PubMed ID: 26408409
[TBL] [Abstract][Full Text] [Related]
11. Transporter genes ABCG2 rs2231142 and ABCB1 rs1128503 polymorphisms and atorvastatin response in Chilean subjects.
Prado Y; Zambrano T; Salazar LA
J Clin Pharm Ther; 2018 Feb; 43(1):87-91. PubMed ID: 28833323
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women.
Issa MH; Cerda A; Genvigir FD; Cavalli SA; Bertolami MC; Faludi AA; Hirata MH; Hirata RD
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):139-44. PubMed ID: 22094353
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.
Zambrano T; Saavedra N; Lanas F; Caamaño J; Salazar LA
Mol Diagn Ther; 2015 Feb; 19(1):45-52. PubMed ID: 25589339
[TBL] [Abstract][Full Text] [Related]
14. Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects.
Anderson JM; Cerda A; Hirata MH; Rodrigues AC; Dorea EL; Bernik MM; Bertolami MC; Faludi AA; Hirata RD
J Clin Lipidol; 2014; 8(3):256-64. PubMed ID: 24793346
[TBL] [Abstract][Full Text] [Related]
15. High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descent.
Rodrigues AC; Rebecchi IM; Bertolami MC; Faludi AA; Hirata MH; Hirata RD
Braz J Med Biol Res; 2005 Sep; 38(9):1389-97. PubMed ID: 16138223
[TBL] [Abstract][Full Text] [Related]
16. No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population.
Giannakopoulou E; Ragia G; Kolovou V; Tavridou A; Tselepis AD; Elisaf M; Kolovou G; Manolopoulos VG
Mol Biol Rep; 2014 Jul; 41(7):4631-8. PubMed ID: 24668570
[TBL] [Abstract][Full Text] [Related]
17. [Effects of ApoE gene polymorphism on the efficacy of atorvastatin in the treatment of hyperlipidemia].
Zhang Y; Wei DD; Yuan RR; Ge QX; Chen F; Yang SX; Chen BP; Shi J
Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(4):291-294. PubMed ID: 28162160
[No Abstract] [Full Text] [Related]
18. The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population.
Wu H; Huang Q; Yu Z; Wu H; Zhong Z
Lipids Health Dis; 2020 Sep; 19(1):202. PubMed ID: 32891149
[TBL] [Abstract][Full Text] [Related]
19. The effect of APOE, CETP, and PCSK9 polymorphisms on simvastatin response in Thai hypercholesterolemic patients.
Wanmasae S; Sirintronsopon W; Porntadavity S; Jeenduang N
Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28851085
[TBL] [Abstract][Full Text] [Related]
20. Gender-Specific Association Between ABCC2 -24C>T SNP and Reduction in Triglycerides in Chilean Patients Treated With Atorvastatin.
Prado Y; Arencibia A; Zambrano T; Salazar LA
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):517-522. PubMed ID: 29178257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
